Hutchinson China's patent boost
Drug developer and distributor Hutchison China MediTech (HCM:AIM) is likely to see earnings forecasts upgraded after extending the patent on its top selling drug by 13 years.The China-focused company, known as Chi-Med, will now...
23 July 2015